EGPAdetabase update.xlsx (29.65 kB)
Download file

EGPAdetabase update.xlsx

Download (29.65 kB)
dataset
posted on 06.08.2021, 03:03 authored by Yukihisa HatakeyamaYukihisa Hatakeyama, Rei Tsukamoto, Kazumi Masuta, Shodai Fujimoto, Rei Takamiya, Miho Ikeda, Kayoko Okamura, Hisashi Ohnishi
Eosinophilic polyangiitis granulomatosa (EGPA) is a vasculitis syndrome that affects small and medium-sized blood vessels throughout the body. The mainstay of treatment is steroids, but there are no standardize We investigated the efficacy, steroid administration, and course of steroid reduction in five patients who were diagnosed with EGPA and treated with mepolizumab for 1 year. Five patients who were diagnosed with EGPA using the American College of Rheumatology criteria and treated with mepolizumab for 1 year were included in our study from 2018–2020.d doses or durations for steroids in combination with mepolizumab.

History

Usage metrics

Licence

Exports